Biodexa Pharmaceuticals plc American Depositary Shs

Last updated September 27, 2026

Organization details

Legal name
Biodexa Pharmaceuticals plc American Depositary Shs
Former names
Midatech Pharma Plc
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
United Kingdom
Headquarters city
Cardiff
Headquarters country
United Kingdom
Fiscal year end
December
Ticker symbol
BDRX
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001643918

Board of directors

Chief executives

Stephen Anthony Stamp · Chief Executive Officer
Since March 2026

Organizations in the same sector, closest in location and size first.

Questions about Biodexa Pharmaceuticals plc American Depositary Shs

Who is the CEO of Biodexa Pharmaceuticals plc American Depositary Shs?

Stephen Anthony Stamp has been Biodexa Pharmaceuticals plc American Depositary Shs's Chief Executive Officer since March 2026.

How many directors are on Biodexa Pharmaceuticals plc American Depositary Shs's board?

Biodexa Pharmaceuticals plc American Depositary Shs's board has 6 directors: Ann Louise Merchant, Fiona Mary Powell, Simon Turton, Stephen Anthony Stamp, Stephen Barry Parker and Vries Simon De.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="biodexa-pharmaceuticals-plc-american-depositary-shs"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.